Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 21.27% vs -9.15% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -470.51% vs 124.06% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 46.74% vs -7.19% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 116.61% vs -24.42% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Cuu Long Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -11.60% vs -4.93% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 21.27% vs -9.15% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -88.95% vs -112.19% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -470.51% vs 124.06% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -23.50% vs -69.06% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 46.74% vs -7.19% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -3.87% vs 33.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 116.61% vs -24.42% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






